Pages that link to "Q43783276"
Jump to navigation
Jump to search
The following pages link to Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. (Q43783276):
Displaying 50 items.
- Molecular mechanisms of pulmonary arterial remodeling (Q26991806) (← links)
- SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis (Q28118787) (← links)
- Cardiovascular and inflammatory effects of intratracheally instilled ambient dust from Augsburg, Germany, in spontaneously hypertensive rats (SHRs) (Q28383982) (← links)
- Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice (Q28590362) (← links)
- Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1 (Q28757126) (← links)
- Targeted cell replacement with bone marrow cells for airway epithelial regeneration. (Q33290207) (← links)
- Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis (Q33442068) (← links)
- Intratracheal gene transfer of adrenomedullin using polyplex nanomicelles attenuates monocrotaline-induced pulmonary hypertension in rats (Q33713831) (← links)
- Attenuation of monocrotaline-induced pulmonary hypertension by luminal adeno-associated virus serotype 9 gene transfer of prostacyclin synthase (Q33782838) (← links)
- Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation (Q34053650) (← links)
- Changes of gene expression after bone marrow cell transfusion in rats with monocrotaline-induced pulmonary hypertension (Q34300770) (← links)
- New treatments for pulmonary arterial hypertension (Q34625826) (← links)
- Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model. (Q34798669) (← links)
- Pulmonary arterial hypertension in congenital heart disease (Q34950123) (← links)
- Paracrine effects of bone marrow-derived endothelial progenitor cells: cyclooxygenase-2/prostacyclin pathway in pulmonary arterial hypertension (Q35048253) (← links)
- Estrogen rescues preexisting severe pulmonary hypertension in rats (Q35527919) (← links)
- Clinical review: gene-based therapies for ALI/ARDS: where are we now? (Q35558172) (← links)
- Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice. (Q35633619) (← links)
- Medical therapeutics for pulmonary arterial hypertension: from basic science and clinical trial design to evidence-based medicine (Q36107232) (← links)
- Targeted delivery of therapeutic oligonucleotides to pulmonary circulation (Q36226756) (← links)
- Growth factor-delivery systems for tissue engineering: a materials perspective (Q36344073) (← links)
- Pulmonary vascular changes 22 years after single lung transplantation for pulmonary arterial hypertension: a case report with molecular and pathological analysis (Q36352139) (← links)
- Role of miR206 in genistein-induced rescue of pulmonary hypertension in monocrotaline model (Q36382227) (← links)
- Mediators and modulators of pulmonary arterial hypertension (Q36477935) (← links)
- Clinical implications for vascular endothelial growth factor in the lung: friend or foe? (Q36625050) (← links)
- Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies (Q36686008) (← links)
- Emerging therapies for pulmonary arterial hypertension (Q36821361) (← links)
- Future perspectives for the treatment of pulmonary arterial hypertension (Q36943648) (← links)
- Smooth muscle protein 22alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling (Q37120634) (← links)
- Signal transduction in the development of pulmonary arterial hypertension (Q37133785) (← links)
- Vascular endothelial growth factor of the lung: friend or foe (Q37158665) (← links)
- VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats (Q37170742) (← links)
- Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation (Q37402084) (← links)
- Current and future therapy for pulmonary hypertension in patients with right and left heart failure (Q37688167) (← links)
- Novel approaches to treat experimental pulmonary arterial hypertension: a review (Q37719245) (← links)
- New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation (Q37724192) (← links)
- Prostacyclin therapy for pulmonary arterial hypertension (Q37789151) (← links)
- The Effects of Antiangiogenic Compound SU5416 in a Rat Model of Pulmonary Arterial Hypertension (Q37813372) (← links)
- Role of endothelial injury in disease mechanisms and contribution of progenitor cells in mediating endothelial repair (Q37868105) (← links)
- Mechanisms of disease: pulmonary arterial hypertension. (Q37892336) (← links)
- Endothelial progenitor cell-based therapy for pulmonary arterial hypertension (Q38072175) (← links)
- Inhalation therapy to treat pulmonary arterial hypertension (Q38162947) (← links)
- Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases (Q38165146) (← links)
- Human pulmonary artery endothelial cells in the model of mucopolysaccharidosis VI present a prohypertensive phenotype (Q38367080) (← links)
- The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies (Q39353707) (← links)
- Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia (Q39752665) (← links)
- The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice (Q42121099) (← links)
- Intralipid Prevents and Rescues Fatal Pulmonary Arterial Hypertension and Right Ventricular Failure in Rats (Q42139850) (← links)
- Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension (Q43270607) (← links)
- MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS. (Q43833798) (← links)